	Ebit		日
Acadia Pharmaceuticals	USD 17.39M	18.36M	2025-12
Adma Biologics	USD 62.75M	13.56M	2025-12
ALKERMES	USD -10.95M	100.03M	2025-12
Alterity Therapeutics Limited	AUD -8.07M	302.4K	2025-12
AstraZeneca	USD 7.11B	4.14B	2026-03
BioCryst Pharmaceuticals	USD 260.38M	230.79M	2025-12
Bristol-Myers Squibb	USD 3.56B	90M	2026-03
Cipla	INR 9.77B	6.21B	2025-12
Clal Biotechnology	ILS -5.44M	3.76M	2022-12
Compugen	USD 56.04M	63.94M	2025-12
CSL	USD 2.64B	116M	2025-12
Eli Lilly	USD 9.78B	792M	2026-03
Esperion Therapeutics	USD 85.23M	95.19M	2025-12
GlaxoSmithKline	GBP 2.29B	856M	2026-03
Grifols	EUR 320.55M	91.01M	2025-12
Halozyme Therapeutics	USD -88.41M	306.33M	2025-12
Ionis Pharmaceuticals	USD -118M	97M	2026-03
J&J	USD 6.62B	1.51B	2026-03
Merck	USD -1.88B	8.12B	2026-03
Minerva Neurosciences	USD -4.37M	1.71M	2024-09
Neurocrine Biosciences	USD 227.9M	11.4M	2025-12
Novartis	USD 4.18B	118M	2026-03
Novavax	USD 20.94M	100.32M	2025-12
Pfizer	USD 4.65B	71M	2025-12
Roche Holding	CHF 9.56B	2.1B	2025-12
Sanofi	EUR 1.94B	239M	2026-03
Takeda	JPY 257.49B	568.56B	2025-12
Vanda Pharmaceuticals	USD -10.28M	721K	2024-12